| Keywords: |
gene mutation; genetics; mutation; cancer risk; treatment planning; disease marker; cancer diagnosis; breast cancer; mastectomy; epidermal growth factor receptor 2; breast neoplasms; brca1 protein; brca2 protein; risk factor; risk assessment; tumor suppressor gene; medical information; genes, brca1; genes, brca2; gene identification; short survey; clinical decision making; neoplasms, second primary; estrogen receptor; progesterone receptor; decision making; genetic screening; germ-line mutation; genetic testing; genetic counseling; trends; contralateral prophylactic mastectomy; germline mutation; humans; human; female; priority journal
|
